Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Transcripts

Read transcripts of webcasts and audiocasts

Transcripts

Read transcripts of webcasts and audiocasts

All regions
Finland
Sweden
Denmark
Norway
Latest
Trending
Followed

Haypp Group, Audiocast with teleconference, Q1'24

By Inderes5/3/2024, 7:00 AM
Haypp Group

Disclaimer: This is a machine-generated transcript and may contain inaccuracies.

Gavin
00:02 - 06:42

Good morning, everybody, and welcome to our Q1 2024 interim results. Starting with the operational highlights. I would like to begin. I would like to begin with our nicotine vaping first quarter volume growth of 40%, which remains robust despite Easter falling in the first quarter. If we run our NP volume performance out to year-to-date end of April, reflecting the Easter effect in both years, you can see that our NP performance accelerated to 42% over those four months. NGP accounted for 58% of our total volumes for the year, up 12 percentage points versus the first quarter of 2023. And the trend continues, with our NP share exceeding 60% in March. We're particularly happy with the continued strong performance of NGP in our growth division, which has also moved into profitability for the first time. This news category moved into overall decline. Overall market decline during 2023, and this is expected to continue for the foreseeable future. These changing dynamics have reduced the brand owners' appetite to invest in either new snus launches or snus promotions. Our consumers greatly value our ability to display new products and our competitive prices. The absence of both has resulted in a decline in our snus sales, slightly faster than that of the overall market. While snus is not a strategically important long-term category for us, we have taken some actions to bring our decline back in line with the market. The increase in our EBIT margin from 2.3% to 3.5% reflects the benefits of scale to our business, particularly in our growth markets. This 3.5 percentage points increase includes an additional 0.8 percentage points, which has been reinvested into emerging opportunities. And our infrastructure transformation continues on track and will be key to our effective continued expansion. Moving to the next slide and taking a look at our emerging market segment. I've taken in the Capital Markets Day. But because our primary focus is the fastest-growing of the three product categories globally, and our existing markets currently account for the vast majority of local and global volume, we also recognize that only 4 million of the existing 100 million users of risk-reduced products are in our current target. This is why we plan to expand into adjacent or RRP categories and new countries. We have first expanded into vaping in some of our existing European markets, which covers an additional 6 million risk-reduced product consumers. While our existing infrastructure and skill set give us a material boost, our granular understanding of the vape category and establishing organic search positions will require persistence over the coming years. We also appreciate the strong relationship between nicotine patches and vaping, with many RRP consumers either previously being vapers or even still being dual users. Finally, we recognize that a wave of regulation regarding disposables is potentially on the horizon in Europe and may alter the landscape for the vape category. In general, we view this disruption as a long-term opportunity and shall dedicate our resources towards this opportunity with a clear appetite to have an economically sustainable slice of the market over the longer term. Moving along to our infrastructure improvements. We are building our total company infrastructure with the principles of sustaining growth in our current markets and ensuring efficient expansion into both adjacent categories and new geographies. We continue to make strong progress in this transformation. During Q1, we replaced our ERP and middleware in Sweden and Growth Europe, bringing all of our European operations onto the destination architecture. This facilitates the migration of our e-commerce stores to V3. Our upgraded system, in addition to the new launch of Vape Globe, the Vape Globe store in Germany in late 2023, we have also successfully migrated our first Norwegian store in recent weeks with minimal disruption. Moving on to our warehouse structure, we plan to automate our Texas warehouse in the latter part of 2024. This will harmonize our warehouse equipment and software, which is working efficiently in our European warehouses. In summary, the team is executing in line with our plans. Moving along to regulation. The new national regulatory initiatives in Sweden reinforce the principle of tobacco harm reduction. In addition, we support potential initiatives which could deter youth access, including restrictions on private persons retailing products and reinforcing product standards, which we at Haypp Group have self-imposed many years ago. In Norway, there has been minimal movement on regulation, and we remain confident that Haypp Group will not be negatively impacted by the potential regulation. In the US, the regulatory framework remains very stable despite some recent concerns from a prominent senator. Youth consumption remains extremely low for nicotine patches. While the upcoming move to the UK. While the upcoming legislation is somewhat later than we initially expected. We generally welcome the legislation and believe that Haypp Group is well positioned to benefit from it. At an EU level, TPD three appears to be even further delayed. This has encouraged more member states to start to regulate NPS themselves. This continues to add even more weight towards appropriate category regulation at an EU level. With that, I will hand over to Peter for more depth on our commercial performance. Good morning everyone. Thank you, Gavin. Let me start with the financial.

Peter
06:42 - 15:11

Overview on a group level, and let me start with sales. So overall, we reported a 12% sales growth on a group level and achieved 888 million sales. If we exclude the unfavorable currency impact, the growth would have been 13%. But there are three key elements which I would like to call out to give a bit of a color behind our sales performance. Gavin already mentioned Easter. So during holiday seasons, it's very typical for us to see a lower order intake. We experience this every time in the Christmas period, every year. That's the usual thing. And this year, because Easter was in March in 2023. In 2023, Easter was in April. And now this year in March. We have to take a better look here at the April performance. We already have the preliminary sales numbers available and, looking at those, year to date, April sales performance is already at 17%. So we can see the correction in the April months. Then the second important element to highlight here is the contribution, the sustained contribution of our growth markets. We can see that those segments are contributing solidly to our overall growth. However, this quarter, the core markets' contribution was lower than historically. And here comes the third part, which Gavin already mentioned: the decline in the small segment. If we look at our sales drivers, net sales drivers, then the nicotine pouch remains solid. However, the smooth decline weighed heavily into our overall growth. With this, let me move to the profitability, because here I think we achieved a major step towards our long-term commitment of the targets we set down on our capital markets day. So our gross margin for the quarter increased by 2.4%. This increase is predominantly driven by the annual commercial renegotiations. And typically such change happens only from Q4 to Q1 and throughout the year it's relatively stable. The margin improvement Was partly reinvested into overheads, into new capabilities and capacity. Particularly behind the new emerging market segment. And overall, this resulted in an adjusted EBIT of 3.5%, an increase of 1.2% from 2.3% in Q1 2023. Important to highlight here that the core and growth markets' EBITDA was at 6.1%, 0.8% out of which was invested into the emerging markets. So the total group EBITDA was at 5.6%. With the depreciation results in the 3.5% adjusted EBIT. I would like to also highlight the cash flow performance from operating activities, because we achieved 122 million SEK positive cash flow. This is a combination of better lower inventory levels after year end, but also mainly driven by improved trading terms with our suppliers for the payables. We reported some exceptional costs in this quarter, and these are connected to the impairment of the retired equipment for the Stockholm warehouse, where in previous years we overhauled the entire infrastructure to improve capacity. Moving to the core markets here. The net sales increased by 2% in Q1. In constant currency, the increase was 3%. Again, year to date. April is an important figure here to bear in mind because that increase is already at an 8% level. We are happy with our nicotine sales performance, which remains strong and grew 32% in the quarter and 34% year to date. April. Based on our understanding, this growth is ahead of the market growth. So indicates that we are gaining share. This new performance, which occurred over the weekend in Q1. It has to be seen also from a long-term perspective. We do not see the category as part of our long-term strategy. There are not enough innovative products coming through from the suppliers, and there is a very low level of appetite to invest in the category by the brand owners, whose focus is clearly shifted towards nicotine pouches. However, we recognize that this new category is not going to disappear. Completely. So we took actions to mitigate this decline, as Gavin already indicated. The adjusted EBITDA grew 6.5% to almost 54 million, reaching 8.6%, up by 0.4 versus last year. This is mainly attributable to a favorable mix impact within the categories. Moving to the growth market. Let me start with the sales, which increased by 46%. Here we saw strong performance across all markets, but especially in the US. Nicotine pouches grew by 59% in the US. I would like to highlight California and the impact of California because, as we talked about a year ago when we announced the Q1 report, we highlighted that due to the flavor ban, Haypp Group also benefited greatly from the increased consumer demand for products which were legally available by online retailers. However, we see that since then many consumers reverted back to using flavored nicotine pouches, which created a temporary headwind for Q1 for us. And this is what we evidently see in our sales in California. However, outside of California, we achieved a 70% growth overall. EBIT is another important element and a great milestone that we reached in the growth market. This quarter, from being a clear profit for the group. This quarter we resulted around the breakeven result, very slight positive adjusted EBITDA, which is clearly driven by economies of scale, very partly offset by commercial investment. And obviously, there is a key role here for the annual commercial negotiations, which have improved our overall margin performance in this market segment. Last but not least, emerging markets here. Financially speaking, there is not too much to say. These categories are in their infancy. So as you can see, we achieved an 8 million SEK in sales. And overall, we invested 7 million on a level, these 7 million investments mainly went into capacity and capability in specific parts of the organization, mainly in commercial search optimization and category management. At this stage, I believe that the success of this category is not to be seen through the financial KPIs, but more on how we can build our positioning and progress in terms of customer acquisition. Within this segment. Let me move to the selected KPIs. I already told you about a strong cash flow performance and strong EBITDA. What we had. The combination of these two is resulting in a nice decrease in our net debt to adjusted EBITDA ratio, which is down to 0.8%. As I look ahead, I believe that our business model will allow us to maintain the capital-lite structure. And maintain our healthy balance sheet so we are ready for the next phase of growth. With that, I give it back to you, Gavin. Thank you.

Gavin
15:11 - 16:59

Thank you. Moving to our financial targets. Uh, we target 5 billion in revenue for 2025 from our core and growth markets. While we recognize that our Q1 overall revenue growth was well below what's required. We would also like to guide you to our overall nicotine pouch growth of over 40%, despite some one-off impacts, and that nicotine pouches now account for over 60% of our sales. Continued strong performance in NPY will continue to lift the overall revenue growth. Regarding profitability, we guide investors towards an adjusted EBIT for core and growth segments in the range of 5 to 7% in 2025. During Q1, our adjusted EBIT for these segments was 4.3%, an increase of two percentage points versus Q1 2023. We would like to remind you that our operating model tends to reflect the benefits of scale as we transition from one calendar year into the next. As such, I expect early 2025 to be the next time when we experience a material uptick in our EBIT margin. Moving to our final slide, I would like to reflect on the dynamics underpinning our continued performance. Our operating model is a substantial mode for our business, which in turn is built on robust processes and systems. However, our overall progress is a result of an excellent team and culture that they have fostered and their connection to our higher purpose of inspiring healthier enjoyment for millions. I would like to take this opportunity to thank the team for their commitment, dedication, and overall performance. And with that, I will hand over to the operator for questions.

Unknown
17:03 - 17:26

If you wish to ask a question, please dial Pound Key five on your telephone keypad to enter the queue. If you wish to withdraw your question, please dial Pound Key six on your telephone keypad. The next question comes from Nicholas Ekman from Carnegie. Please go ahead.

Marianne
17:27 - 17:55

Thank you. Yes. A couple of questions for Marianne. Firstly, if I could start maybe with the growth target here of 5 billion by 2025. Um, given the slowdown you're seeing and how confident are you, because I think this requires the sales CAGR of 28% over the next seven quarters, how confident are you that you can see that level of acceleration and that the slowdown you saw here in Q1 was really very temporary?

Gavin
17:57 - 19:48

Good morning, Nicholas. Yeah. So I think there's a couple of dynamics in this one. Um, I think the first dynamic running through this, I think we very much have to view it towards probably three different layers sitting within us. And the way I would lay the layers out would be at the bottom level is snus. And what level of decline will be manifesting through that at the next level? Nicotine pouches within our core markets and then at the top level, nicotine pouches within our growth markets. And what we can see is that now, roughly one third of our sales is coming in each of those segments, or just we call it simplistically, one third of our sales coming in each of those segments. But what we can see is accelerating growth in that top layer of nicotine pouches in our growth markets, continued robust growth operating well above that 25 to 28% level that you're referring to for nicotine pouches in our core markets. And of course, we have been experiencing that headwind on snus. Now, regarding snus, we always expected that there was going to be a decline. I think what has been sort of interesting to us over the last maybe 5 or 6 quarters is realizing that it's not constant. It does come in ebbs and flows a little bit as it comes through here. So we still remain confident for the overall numbers. We recognize that we are going to have to navigate what this new dynamic within it will be. But we also recognize on this one, that we're maintaining our primary focus on nicotine pouches, because that is where not just the growth is coming from, but it's also where all of our margin comes from. I think, as Peter alluded to in some of his slides, part of the reason why we've been seeing the margin expansion in our core markets has been the mix change away from nicotine pouches towards this. So we remain confident, um, for those sort of key factors going through it.

Marianne
19:52 - 20:20

Thank you. That's very clear. And a second question. Um, if you can elaborate a bit on the margin development here, is it right to understand that because of renegotiating the contracts, we can now expect basically a plus one percentage point margin improvement throughout 2024. And you believe this could accelerate even more to more than one percentage point margin expansion in 2025. Is that the right way to understand this?

Gavin
20:21 - 21:11

Directionally. Absolutely. So the calendar, as you sort of alluded to, the negotiations are done on an annual basis, and we've taken more than two percentage points out of core and growth with the uptake in it. And this was why we felt that as we knew this was coming, as we went through 2023, we felt it was an opportunity to be able to utilize some of that to invest into our emerging opportunities. Hence, where you can see the 80 basis points of margin reinvested into there. So we do expect that to continue during the year. Like I said, I don't expect to see that level of uptake that we've seen from Q4 to Q1 occurring in other quarters during 24. But again, I would expect that, you know, that type of step change would be anticipated again in early 2025, that wouldn't come across as a great surprise.

Marianne
21:14 - 21:35

Excellent. And can you elaborate a bit on the pricing environment as well? Is your ability to keep these benefits? Um, do you think that you will be able to absorb these, um, cost efficiencies fully, or do you see any price competition in the market, um, or anything else, or do you have an ability to raise prices in the market?

Gavin
21:36 - 22:22

Yeah. No, our model is that we will generate the bottom line without closing the pricing gaps on any competition. And we quite like the pricing gaps where they are. We believe they're a good reason for people to maintain or accelerate the migration from offline to online. So we're not particularly interested in closing the price gaps, bearing in mind how competitive or how rapidly growing the category already is, we're very keen to continue to take share within it. So we see that we can maintain the price gaps and that what you're getting coming through in the form of increased margin is predominantly falling out from both the economies of scale, both directly within our operations and of course, with support from our business partners.

Marianne
22:24 - 22:51

Very clear. Thank you. Um, final question. If you could just help me define what you characterize as emerging markets. You say here that it's your vaping operations in the U.K., Sweden, and Germany, but you also talk about new markets. Are you then referring to the expansion of vape into new markets, or would you also classify a new nicotine pouch market? Would that also be included in emerging markets as you define it?

Gavin
22:52 - 23:28

Exactly. So when we laid this out as regards to the position of the Capital Markets Day, and we wanted to cover the next couple of years, bringing us up to the end of 2025. So we're grouping things together here, all of which will be manifesting during 2025 between now and the end of 2025. The first one being, as you said, the expansion into adjacent categories in our existing geographies. And then as we get further along through that timeframe, we will expand into new geographies both with vape and with nicotine pouches. So it's a segment that captures both over that two-year window.

Marianne
23:31 - 23:54

Very, very clear. And just to follow up there. Can you tell us a little bit about your development here in new markets, what new markets have you launched nicotine pouches in, in say, the past 12 months. And how do you see that progressing over the next 12, 18 months? Do you have a long list of markets where you wish to enter, or is this a very slow, gradual process?

Gavin
23:54 - 25:16

Okay. Apologies if my last point was perhaps unclear on this one, Nicolas. So I view it between now and late 2025, whereby we will first expand into vape in existing geographies. So hence the Sweden, Norway, and the UK. And as we gain traction and that at some point during that two-year window, we will expand into new geographies with both vape and nicotine pouches. At this point in time, we have not expanded into new geographies with the category at this stage, and this is partly because we feel we can get more initial return on our energy by entering into markets where we already have the warehouse infrastructure, and the store infrastructure is up and running, but also with the new infrastructure that we've been rolling out for both our ERP and middleware, and that we're now starting to roll out for our storefronts, that makes it substantially easier for us to roll out new geographies and new stores in new geographies in the future. So hence why we're taking it in this order. So, to paraphrase, we are in no new markets in the last few years, and we are slowly expanding first into vape in some of our existing markets. And as we get into the latter part of this year and early next year, we will start moving out towards new geographies at that stage.

Marianne
25:18 - 25:22

Super. That's very clear. Thank you so much for taking my questions.

Gavin
25:22 - 25:24

Thank you. Nicholas and Nicolas.

Unknown
25:30 - 25:52

As a reminder, if you wish to ask a question, please dial Pound Key five on your telephone keypad. There are no more questions at this time, so I hand the conference back to the speakers for any closing comments.

Gavin
25:54 - 26:07

Thank you all very much for your time. I greatly appreciate it this morning and look forward to catching up with you in three months' time for our Q2 performance. Thank you. Goodbye. Thank you. Goodbye.

Continue to the webcast
Revenio Group Oyj, Q3'26
Language: English11/12/2026, 1:00 PM
Jukka Kainulainen Good afternoon, and welcome to the Revenio Group Corporation Q3 Earnings Call. My name is Jouni Toijala. I am the CEO. And then, again today we have Jukka Kainulainen, our CFO, on th…
Kamux, Q3'26
Language: English11/12/2026, 9:00 AM
Katerina Heterant Good morning. Welcome to the Kamux Q3 results presentation. My name is Katerina Heterant and I am Head of Investor Relations at Kamux. Today we shall go through the Q3 results presen…
Koskisen, Webcast, Q3'26
Language: Finnish11/12/2026, 8:00 AM
Jukka Pahta Hyvää huomenta ja tervetuloa tähän osavuosikatsaustilaisuuteen! Koskisen tammi–syyskuun osavuosikatsaustilaisuuteen lähdetään otsikolla: Koskisen liikevaihdon kasvu jatkui. Kohonneet kusta…
Reaktor, Q3'26
Language: Finnish11/11/2026, 9:00 AM
Pekka Horo Oikein hyvää aamupäivää kaikille ja tervetuloa tähän meidän webcastiimme. Olen Pekka Horo, Reaktorin toimitusjohtaja, ja kanssani täällä on tänään Antti Akkanen, joka aloitti lokakuussa Rea…
Savox, Q3'26
Language: English11/10/2026, 11:00 AM
Paulina Tanila Our speakers today are CEO Jerry Kettunen and CFO Juha Järvi. Jerry will give an overview of Savox as a company and go through the highlights of the quarter. After that, Juha will conti…
Raisio Oyj, Webcast, Q3'26
Language: Finnish11/10/2026, 10:00 AM
Elli Siltala Hyvää marraskuista päivää Raisiosta! Ja tervetuloa Raision tammi-syyskuun 2026 osavuosikatsauksen webcastiin! Pahoittelut pienistä teknisistä haasteista, mitä meillä oli tässä alussa. Min…
Mandatum Oyj, Audiocast, Q3'26
Language: English11/10/2026, 9:00 AM
Lotta Borgström Good morning, everyone, and welcome to the Mandatum Q3 2026 audiocast. My name is Lotta Borgström from Investor Relations. Joining me today are our CEO, Petri Niemisvirta, and our CFO,…
Solar foods Go-to-market Update
Language: English11/9/2026, 12:00 PM
Maria Hello everyone, and welcome to the Solar Foods go-to-market update. My name is Maria and I'm here today with our CEO, Rami Jokela, and CFO and Deputy CEO, Ilkka Saura. Also with us today is Heli…
Outokumpu, Webcast, Q3'26
Language: English11/6/2026, 12:30 PM
Johan Welcome to the third quarter results webcast. I am responsible for investor relations. We will start with the presentation from our CEO, Kati ter Horst, and our CFO, Marc-Simon Schaar. After the…
Endomines, Webcast, Q3'26
Language: English11/5/2026, 1:00 PM
Andy Turpin Hello, everyone, and welcome to Endomines' third-quarter results webcast. Thanks for joining us today. My name is Andy Turpin and I am the Chief Communications Officer here at Endomines. A…
Lemonsoft Oyj, Q3'26 webcast
Language: English11/5/2026, 11:00 AM
Unknown 1 Welcome to the Lemonsoft Q3 results presentation. We will start with the presentation from CEO Alpo Luostarinen, followed by the Q&A. You can send your questions throughout the event via the…
Enersense, Webcast, Q3'26
Language: English11/5/2026, 10:30 AM
Liisa Tamminen Hello and welcome to the Enersense Q3 2026 results webcast. My name is Liisa Tamminen from Enersense Investor Relations. And with me here I have our CEO, Kari Sundbäck, and CFO, Jan-Elo…
Sitowise, Q3'26
Language: English11/5/2026, 10:00 AM
Mari Reponen Good day everyone, and welcome to the Sitowise Q3 2026 results audiocast. My name is Mari Reponen, and I am responsible for strategy and IR here at Sitowise. And today with me are our act…
Orthex, Webcast, Q3'26
Language: English11/5/2026, 9:00 AM
Alexander Rosenlew Good morning and welcome to the Orthex Interim Report. My name is Alexander Rosenlew and with me I have Saara Mäkelä, CFO, and Hanna Kukkonen, our CMSO. We will take you through the…
Suominen Oyj, Q3'26
Language: English11/5/2026, 8:30 AM
Anni Luoma Good morning, everyone, and welcome to the Suominen Q3 webcast. My name is Anni Luoma. I am the Manager of External Communications and Investor Relations at Suominen. Here with me are our P…
Lumo, Webcast, Q3'26
Language: English11/5/2026, 8:00 AM
Niina Saarto Good morning, all. Welcome. This is Lumo Homes plc's third quarter result webcast. I am Niina Saarto from Treasury and Investor Relations. Today I have two gentlemen here with me, namely…
CapMan, Webcast, Q3'26
Language: English11/5/2026, 7:30 AM
Charlotte Good morning and welcome to this presentation of CapMan. Q3 2026 interim report. Presenting today we have Pia Kåll, CEO of CapMan. And after the presentation, we will have a Q&A session. You…
Marimekko, Webcast, Q3'26
Language: English11/4/2026, 12:00 PM
Anna Good afternoon. My name is Anna and I am the IRO of Marimekko. It is my pleasure to welcome you to our Q3 webcast. With me, I have our president and CEO, Tiina Alahuhta, who will walk you through…
Administer, Webcast, Q3'26
Language: Finnish11/4/2026, 9:00 AM
Kimmo Herranen Welcome to the Administer Q3 2026 interim report. Results. Meillä on se alkaa. I am Kimmo Herranen. Kalle Lehtonen. Also. Kaarina og. Yelken. Kalle Lehtonen En el coco. Madan. Parannus.…
Kempower, Webcast, Q3'26
Language: English11/4/2026, 8:30 AM
Unknown 1 Powering the planet. Kempower. We charge our planet for the better. By powering the electric movement. We enable quick and scalable EV charging solutions for everyone and everywhere. We ma…